Today: 19 May 2026
Browse Category

ASX:GMG 23 December 2025 - 9 February 2026

Australia stock market today: ASX 200 jumps nearly 2% as tech rebounds; Pepper Money spikes on bid

Australia stock market today: ASX 200 jumps nearly 2% as tech rebounds; Pepper Money spikes on bid

The S&P/ASX 200 jumped 1.85% to 8,870.1 on Monday, erasing much of Friday’s losses as tech and real estate stocks led gains. Car Group surged 9.9% after strong results, while Pepper Money soared on a takeover bid. Australian household spending fell 0.4% in December. Traders now await major bank earnings and key U.S. economic data this week.
Australia Stock Market Today: ASX 200 climbs toward 8,800 as Goodman surges on $14bn data-centre deal; RBA minutes revive 2026 rate-hike debate

Australia Stock Market Today: ASX 200 climbs toward 8,800 as Goodman surges on $14bn data-centre deal; RBA minutes revive 2026 rate-hike debate

The S&P/ASX 200 climbed 1.13% to 8,798.40 by 3:30pm AEDT Tuesday, hitting a 20-day high as Goodman Group surged 8.6% after announcing a A$14 billion data centre partnership with CPPIB. DroneShield also gained 6.6%. A major Westfield Sydney property deal and a more hawkish RBA tone contributed to the session’s momentum.
23 December 2025

Stock Market Today

  • Ito En Shares Slide 10% in Year Despite Revenue Growth; Valuation Called Overpriced
    May 18, 2026, 10:51 PM EDT. Ito En (TSE:2593) stock declined about 10% over the past year with a 5% drop in the last month, reflecting fading momentum despite positive revenue and net income growth. The company trades at a high price-to-earnings (P/E) ratio of 123.4x, significantly above its fair value estimate of 71.8x and the Asian Beverage industry average of 18.9x. This elevated P/E suggests investor expectations for strong future profit growth, even as recent earnings were hit by a ¥15.3 billion one-time loss, reducing profit margins to 0.5% from 2.7%. Discounted cash flow (DCF) models also indicate the current share price may be overvalued, with a fair value around ¥1,561.46 per share compared to the closing price near ¥2,892.5. Investors should consider valuation risks amid mixed signals on Ito En's growth outlook.

Latest articles

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

Nasdaq gives up after-hours gains as oil and yields weigh on Wall Street rally

19 May 2026
Dominion Energy shares jumped 9.4% after agreeing to an all-stock merger with NextEra Energy, whose shares fell 4.6%. The S&P 500 slipped 0.1% and the Nasdaq dropped 0.5% as investors sold technology stocks amid rising Treasury yields and oil prices. Nvidia fell 1.4% ahead of earnings. U.S. crude settled at $107.37, and the 10-year Treasury yield reached 4.59%.
XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

XP Shares Slip Post-Q1, Buyback Fails to Sway Investors

19 May 2026
XP Inc.’s U.S.-listed shares fell 3.78% in after-hours trading Monday after reporting higher Q1 profit but weaker net inflows and a lower retail take rate. Net income rose 7% to 1.32 billion reais, but net inflow dropped to 14 billion reais from 24 billion a year earlier. The company declared a $0.20 dividend and announced a new CFO, Gustavo Alejo Viviani, starting August 3.
LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

LiveRamp Rallies 27% After Publicis $2.5 Billion Cash Bid

19 May 2026
Publicis Groupe agreed to buy LiveRamp Holdings for $38.50 a share in cash, valuing the U.S. data-collaboration firm at $2.546 billion. LiveRamp stock jumped to $37.77 on the news, while the broader market fell. LiveRamp reported fiscal Q4 revenue of $206 million, up 9% from a year earlier. Publicis said the deal will boost its adjusted earnings per share from the first year after closing.

Popular

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

Sunshine Biopharma Shares Volatile After $6M Deal, 50-Cent Mark in Focus

19 May 2026
Sunshine Biopharma shares surged as much as 516% before settling up 78% at $0.51 in heavy after-hours Nasdaq trading Monday, following a $6 million public offering priced at $0.50 per unit. More than 436 million shares changed hands, far exceeding the company’s 5 million shares outstanding. The deal includes 12 million units with warrants, raising dilution concerns. Closing is expected around May 19.
Go toTop